Fresenius Medical Care AG (FMS) Gains from Sales and Divestitures (2016 - 2017)
Fresenius Medical Care AG (FMS) recorded quarterly Gains from Sales and Divestitures of $32.2 million in Q4 2017, up 510.23% quarter-over-quarter from $5.3 million in Q4 2016, and up 510.23% on a YoY basis from $5.3 million in Q4 2016.
Fresenius Medical Care AG (FMS) Gains from Sales and Divestitures (2016 - 2017) Analysis & Trends
Fresenius Medical Care AG's Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $32.2 million for Q4 2017.
- In Q4 2017, Gains from Sales and Divestitures rose 510.23% year-over-year to $32.2 million; the TTM figure through Dec 2017 stood at $32.2 million (up 510.23% YoY), while the FY2017 annual figure was $32.2 million, up 510.23% from the prior year.
- Gains from Sales and Divestitures was $32.2 million for Q4 2017 at Fresenius Medical Care AG, up from $5.3 million in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $32.2 million in Q4 2017 to a low of $5.3 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | Concentra Group Holdings Parent | 3.59 Bn | 3.54 Bn | 170.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 32.17 Mn |
| Dec 31, 2017 | 32.17 Mn |
| Dec 31, 2016 | 5.27 Mn |
| Dec 31, 2016 | 5.27 Mn |